Basic information Safety Supplier Related

2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro-

Basic information Safety Supplier Related

2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro- Basic information

Product Name:
2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro-
Synonyms:
  • 2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro-
  • HIF-C2
  • HIF-2 Antagonist 2
  • TC-S 7009
  • N-(3-Chloro-5-fluorophenyl)-4-nitrobenzo[c][1,2,5]oxadiazol-5-amine
  • HIF-2 inhibitor 2
  • HIF Inhibitor VII - Calbiochem
  • N-(3-Chloro-5-fluorophenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine
CAS:
1422955-31-4
MF:
C12H6ClFN4O3
MW:
308.6524432
Mol File:
1422955-31-4.mol
More
Less

2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro- Chemical Properties

Boiling point:
430.2±55.0 °C(Predicted)
Density 
1.652±0.06 g/cm3(Predicted)
storage temp. 
room temp
solubility 
DMSO: soluble15mg/mL, clear
form 
Yellow powder
pka
-2.82±0.48(Predicted)
color 
white to beige
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or DMF may be stored at -20°C for up to 1 month.
InChI
1S/C12H6ClFN4O3/c13-6-3-7(14)5-8(4-6)15-10-2-1-9-11(17-21-16-9)12(10)18(19)20/h1-5,15H
InChIKey
CDQUJZKBRAFWNG-UHFFFAOYSA-N
SMILES
Fc1cc(cc(c1)Nc2c(c3n[o]nc3cc2)[N+](=O)[O-])Cl
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25
Safety Statements 
45
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
Storage Class
11 - Combustible Solids
More
Less

2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro- Usage And Synthesis

Description

HIF-2α-I2 (1422955-31-4) is a potent and selective HIF-2α inhibitor, Kd=81 nM.1Binds to the HIF-2α PAS-B domain2and interferes with Hif-2α / ARNT heterodimerization reducing target gene expression in a cellular model1. Highly selective for HIF-2α displaying a >60-fold selectivity over HIF-1α.1,2

Uses

N-(3-Chloro-5-fluorophenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine is a HIF-2α inhibitor which inhibits HIF-2α-ARNT heterodimerization by binding to HIF-2α PAS-B domain. It may be used in therapeutic treatment of HIF-2-driven tumors such as renal cell carcinomas.

storage

Store at RT

References

[1] THOMAS H SCHEUERMANN. Allosteric inhibition of hypoxia inducible factor-2 with small molecules[J]. Nature chemical biology, 2013, 9 4: 271-276. DOI:10.1038/nchembio.1185
[2] MATTEO MASETTI  Maurizio R  Federico Falchi. Protein dynamics of the HIF-2α PAS-B domain upon heterodimerization and ligand binding.[J]. PLoS ONE, 2014: e94986. DOI:10.1371/journal.pone.0094986
[3] JAMIE L. ROGERS. Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor[J]. Journal of Medicinal Chemistry, 2013, 56 4: 1739-1747. DOI:10.1021/jm301847z

2,1,3-Benzoxadiazol-5-aMine, N-(3-chloro-5-fluorophenyl)-4-nitro-Supplier

AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Email
info@adooq.com
Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Email
product02@bidepharm.com
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Email
info@adooq.cn
SPIRO PHARMA
Tel
Email
eric_feng1954@126.com
Shanghai Haozhixiang Biotechnology Co., Ltd
Tel
526763801 13301653310
Email
526763801@qq.com